Search Results - W. Hiddemann
- Showing 1 - 5 results of 5
-
1
S301: GERMAN AMLCG-SURVIVORSHIP STUDY: QUALITY OF LIFE AND LIFE SATISFACTION IN AML LONG-TERM SURVIVORS by E. Telzerow, D. Görlich, C. Sauerland, A. S. Moret, M. Rothenberg-Thurley, F. H. A. Mumm, S. Amler, W. E. Berdel, B. Wörmann, U. Krug, J. Braess, P. Heussner, W. Hiddemann, K. Spiekermann, K. H. Metzeler
Published in HemaSphere (2022-06-01)Get full text
Article -
2
P558: GERMAN AMLCG-SURVIVORSHIP STUDY – SOMATIC LONG-TERM CONSEQUENCE OF AML AND ITS THERAPY: FROM HEART TO KIDNEY. by A. S. Moret, E. Telzerow, C. Sauerland, M. Rothenberg-Thurley, F. H. A. Mumm, J. Braess, B. Wörmann, U. Krug, W. E. Berdel, W. Hiddemann, K. Spiekermann, P. Heußner, K. Kraywinkel, D. Görlich, K. H. Metzeler
Published in HemaSphere (2022-06-01)Get full text
Article -
3
P416: CLONAL HEMATOPOIESIS IS COMMON IN AML LONG-TERM SURVIVORS AND MAY ASSOCIATE WITH DIABETES AND SECONDARY NEOPLASIAS, BUT NOT OTHER HEALTH OUTCOMES by S. M. Krauß, E. Telzerow, A. S. Moret, D. Richter, M. Rothenberg-Thurley, D. Görlich, M. C. Sauerland, W. E. Berdel, B. Wörmann, U. Krug, J. Braess, P. Heussner, W. Enard, W. Hiddemann, K. Spiekermann, U. Platzbecker, K. H. Metzeler
Published in HemaSphere (2022-06-01)Get full text
Article -
4
S206: OBINUTUZUMAB PLUS CHEMOTHERAPY DEMONSTRATES LONG-TERM BENEFIT OVER RITUXIMAB PLUS CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: FINAL ANALYSIS OF TH... by W. Townsend, W. Hiddemann, C. Buske, G. Cartron, D. Cunningham, M. J. Dyer, J. Gribben, E. Phillips, M. Dreyling, J. F. Seymour, A. Grigg, T.-Y. Lin, X.-N. Hong, D. Kingbiel, T. G. Nielsen, A. Knapp, M. Herold, R. Marcus
Published in HemaSphere (2022-06-01)Get full text
Article -
5
P479: DNA METHYLATION PROFILING REFINES THE PROGNOSTIC CLASSIFICATION OF ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH INTENSIVE CHEMOTHERAPY by S. Vosberg, A. Ohnmacht, C. Moser, A. Arneth, V. Jurinovic, K. H. Metzeler, M. C. Sauerland, D. Görlich, W. E. Berdel, J. Braess, S. Amler, U. Krug, W. Hiddemann, K. Spiekermann, C. C. Oakes, M. P. Menden, T. Herold, P. A. Greif
Published in HemaSphere (2022-06-01)Get full text
Article
